Laura Devlin (@elldev33) header
Laura Devlin (@elldev33) profile picture

Gardener, Herbalism enthusiast. Pharmacist Passionate about deprescribing

Joined February 2011
Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)
Laura Devlin retweeted
"I don’t just think antidepressants are overprescribed, I’m not convinced they’re useful at all. Antidepressants don’t rectify a chemical imbalance or any other biological process, as people were led to believe; they numb emotions" "The question is, is this useful, and how harmful are they?" 👇 telegraph.co.uk/health-fitne…
43
111
26
360
47,566
Laura Devlin retweeted
We need to talk more about late onset/cumulative drug effects for medications more. Not the effects you get when you first start taking them. I mean the ones that creep up on people bit by bit slowly diminishing their health and quality of life. Where is the informed consent for this?
9
12
56
1,287
Laura Devlin retweeted
They need our help. Now more than ever. Bring the California refugees home.
655
3,931
422
19,143
1,019,330
Laura Devlin retweeted
“SSRIs are whole-body drugs whose full effects we still don’t understand. Even Prozac’s label admits its exact mechanism is unknown. And no, it’s not correcting a serotonin deficiency. That’s marketing.” 🔥
One shitty Iranian trial of 40 kids inflated Prozac’s benefit in two major meta-analyses. Remove the trial and the benefit halves. Think of this the next time your doctor condescends to you about “the Science.” This is the science. Cochrane’s 2021 review found Prozac offered just 2.84 CDRS-R points over placebo (96-point range): “small and unimportant.” Kirsch’s adult analysis found 1.8 HAM-D points over placebo. That’s 40% below the NICE benchmark for a clinically meaningful benefit. These are the numbers behind all that hubris. SSRIs are whole-body drugs whose full effects we still don’t understand. Even Prozac’s label admits its exact mechanism is unknown. And no, it’s not correcting a serotonin deficiency. That’s marketing. Lilly’s own correspondence reveals instructions to code suicide attempts as “overdoses” and suicidal thoughts as “depression.” Courts have found antidepressants responsible for egregious homicides and murder-suicides, even at normal prescribed doses. Severe sexual side effects can persist for decades after stopping these drugs. For some people, getting off means years of careful hyperbolic tapering, down to fractions of a milligram. And we’re giving these drugs to children like they’re Tylenol. This has to stop.
14
2
59
1,182
This is certainly the most consequential paper published in child and adolescent psychiatry for the last few years. It shows that the meta-analyses that current child psychiatry guidelines rely on to recommend fluoxetine for depression were skewed by an unbelievable trial (n=40) in Iran which found an effect 15 times larger than the average. When this trial is removed all meta-analyses find the same as a recent Cochrane analysis which found 'small and unimportant differences.' The flawed meta-analyses by Zhou and @cipriani in the @TheLancet and Lancet Psychiatry need to be corrected. And guideline committees need to update their guidance in the context of the harms of these drugs including withdrawal effects, sexual effects and agitation/akathisia and suicidality in a minority of youths exposed to them. Link below
28
228
32
733
74,553
In an analysis of drug withdrawal to the FDA adverse effects database here were the signals for the 20 drugs with strongest risk of withdrawal. Paroxetine, duloxetine and venlafaxine where in the top 20. Paroxetine was no. 4, above several opioids.
39
81
14
307
49,249
Laura Devlin retweeted
My dad died Wednesday at 91. It’s never long enough. In his final hours, we took him from the hospital back to memory care so they could be together. Two months shy of 67 years of marriage.
1,830
4,637
423
182,613
7,653,692
Laura Devlin retweeted
When you take an SSRI you are not correcting a chemical imbalance... you are inducing one. Be aware of those consequences. They are not benign.
46
173
14
1,055
26,299
The Australian Journal of General Practice from @RACGP published out letter today titled 'The importance of minimising long-term antidepressant use'. Given there is no robust evidence of benefit (discontinuation trials are confounded and not reliable) but evidence of harm we should be aiming to minimise long term use of these medications. Link below.
5
34
1
84
2,602
Laura Devlin retweeted
When I was thirteen, my best friend died and I reacted in myriad unhealthy ways, so my parents took me to a psychiatrist and I was disgnosed with depression and prescribed Zoloft, an anti-depressant. But I wasn’t clinically depressed; I was sad, and I had a good reason to be. So, I think a good thing for a lot of young people to hear is that being sad is okay because sometimes life sucks, but that doesn’t mean you’re depressed or something is wrong with you. Your emotions might just be working the way they’re supposed to.
107
272
23
4,270
113,258
Replying to @markhoro
Having served 9 years as the Consumer Rep on FDA’s Psychopharmacologic Drugs Advisory Committee, I saw firsthand how surrogate endpoints, prior failed studies, “breakthrough” designations and fast-tracking for “unmet need” can lower the hurdle for getting drugs to market. Consumers and doctors need to better understand what “FDA approved” actually means, including what remains unknown. It has been an eye opening experience.
4
6
1
30
2,248
Agree with Prof Ostacher here. The FDA is not fit for purpose when it lets a drug onto the market with 10 out of 12 failed trials (2 barely positive) and overall no effect. This means patients will be exposed to a host of harms for no benefit. Will this approval be reversed ? Who is responsible at the FDA for this approval?
Replying to @FDA
@US_FDA really needs to change its rules. We don't need drugs that fail in multiple trials only to succeed in two. Paroxetine (Paxil) is another drug that probably should not have made it to market, but alas... @markhoro
6
20
3
80
10,052
Patients often wonder what they can do to help bring safer deprescribing. All should report their adverse drug reactions and problems deprescribing to FDA via Medwatch Reporting. FDA is taking them seriously, reading them, and contacting patients. See link in comments below.
3
8
1
34
918
Laura Devlin retweeted
The FDA approved gepirone extended release for #Depression based on 2 positive trials despite 11 negative or inconclusive trials, highlighting the agency's use of regulatory flexibility and trial-level statistical significance. ja.ma/3SmbQIX
13
2
30
5,057
Thoughtful attempt here to understand what might be the molecular mechanisms of protracted withdrawal states (recognised for all psychiatric drug classes): "Treatment discontinuation is not simply a pharmacological absence. It is an active neuroadaptive state shaped by pharmacodynamic rebound, allostatic counterregulation, and gene-regulatory carryover that can persist well beyond drug clearance" Sad that some other clinicians/academics want to pretend that because they don't understand what is going on that it must not be going on....and must be something wrong with the patient. nature.com/articles/s41386-0…
12
34
1
91
4,311
Laura Devlin retweeted
Masculinity isn't toxic. It's necessary. Here's to XY. From the only brand that knows the difference between men and women. @xx_xyathletics
236
2,270
89
20,521
380,682
PUBLIC SERVICE ANNOUNCEMENT: Withdrawal symptoms from your SSRI do not indicate your 'depression is returning' & you must be on an SSRI's for life. Its withdrawal. Anyone who tells you otherwise... run. Don't look back. Find a competent healthcare professional.
7
42
3
200
5,826
Laura Devlin retweeted
I wonder when he’ll figure out they’re the same people at different stages of “treatment”?
7
31
3
104
4,805
Laura Devlin retweeted
Serotonin plays a crucial role in bone health & SSRIs have chemical effects on bone. In this NEW STUDY, serotonergic antidepressants (eg SSRI/SNRIs) were associated with more than a 2-fold increase in the odds of nonunion following spinal fusion. "exposure to SSRIs impairs osteoblast differentiation, reduces mineralization, & degrades trabecular bone microarchitecture, reflecting a shift toward impaired bone formation & increased resorption." thespinejournalonline.com/ar…
8
38
4
116
7,873